The measure, built in dialogue with the government, aims to support families and ensure access to treatments for various health conditions

Ease Labs is the second among the five companies with the highest market volume to announce price reductions

Research with elite competitors points to effectiveness in recovery, but warns of risks of accidental doping in CBD use

Diagnosed with multiple sclerosis, the content creator found in the use of light cannabis and daily affection ways to reinvent her own time and rediscover lightness

A 55-year-old patient in Campo Grande obtained free access to the medication after action by the Public Defender's Office of MS

Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD

Previously, the teenager's mother had to discontinue cannabis treatment due to the high cost of the medication - R$3,000 monthly

Public consultation is launched for preliminary version, but sector agents' criticisms question the scope and composition of the medication

The interpreter of Bebel from "A Grande Família" discovered the disease in 2020 and reveals that the results with CBD oil treatment have been very good.

The deputies want the government to answer six questions, one of them regarding the incorporation in the SUS of a specific product linked to only one manufacturer and not related to the active ingredient

The Health Department of the Federal District has opened a bidding process for the purchase of cannabidiol-based medication, intended for patients with severe epilepsy treated by SUS-DF

Deputy criticizes state bureaucracy and advocates for free supply of cannabis-based medicines through SUS in Santa Catarina

Cannabis-based products could generate around $61 billion by 2026 worldwide

New research relies on rigorous methodologies, such as double-blind studies, and investigates the potential of lesser-known cannabinoids, such as CBG and THCV

Meeting of the State Health Council discussed new protocols and free access to cannabis-based products in the public network

Researchers identify three new cannabinoids, cannabisol, canabitwinol, and canabizetol, with promising therapeutic properties, expanding the boundaries of science on Cannabis sativa

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis: the three diseases treated with cannabis by the SUS in São Paulo

With direct application to the skin, CBD cream offers localized therapeutic effects, being a safe alternative for muscle pain, inflammation, and dermatological problems

Pioneering initiative in Brazil is nationally recognized for its impact on healthcare assistance and already benefits 247 patients in the state